Pavan Choksi

Pavan Choksi is currently a Partner at Arkitekt Ventures based in New York City, New York. Before assuming his current position in October 2021, he served as Co-Founder and Vice President of Business Development at Rx.Health from August 2016 until its acquisition by Commure in October 2023. His earlier career includes a healthcare investment banking role at Piper Jaffray and an ongoing position on the Strategic Advisory Board for the Digital Medicine Society since May 2019. At Arkitekt Ventures, Choksi manages early-stage investments across a portfolio that features prominent companies such as Paradromics, Parsley Health, and Freenome, while also participating in recent funding rounds like the $10 million Series A for Olli Health. His current investment focus centers on advancing human health through frontier technologies, including artificial intelligence, neurotechnology, and quantum computing applied to clinical medicine.